headnote
[This headnote is not to be read as part of the judgment]
These proceedings involved a contested probate application concerning two wills executed by the testatrix in NSW (in 2017) (the Australian will) and Thailand (in 2020) (the Thai will). The plaintiff, the daughter of the testatrix, sought to have letters of administration with the Australian will annexed granted to her. By cross-claim, the second defendant, the testatrix's son, sought letters of administration with the Thai will annexed granted to him, or alternatively an order that probate be granted to the executor of the Thai will. The two wills deal with substantially the same property, appoint the same executor, and divest beneficial entitlements to the plaintiff and second defendant, though to varying degrees.
The plaintiff sought to have the validity of the Australian will upheld, despite the Thai will complying with formal validity requirements, on the basis that the testatrix did not have testamentary capacity, or knowledge and approval, when executing the Thai will. In November 2018, the testatrix was diagnosed with lung cancer, which subsequently metastasised to her brain. By June 2020, when the Thai will was executed, the testatrix had undergone radiotherapy and chemotherapy treatments, and was taking numerous medications and supplements to treat her cancer. The plaintiff claimed that the testatrix was not of sound mind when the Thai will was executed on account of the physical and mental effects of these various treatments. Separately, the plaintiff contended there were suspicious circumstances surrounding the execution of the will such that the testatrix did not have the requisite knowledge and approval. In the event that the Thai will was deemed to be a valid testamentary instrument which superseded the Australian will, the plaintiff brought a separate claim for family provision to be made in her favour.
The issues for determination were:
(i) whether the Thai will was, formally, a valid testamentary instrument;
(ii) whether, despite the above, the Thai will lacked essential validity;
(iii) if the Thai will was a valid testamentary instrument, whether a family provision order should be made thereunder in the plaintiff's favour; and
(iv) whether letters of administration with the Thai will annexed be granted to the second defendant or, alternatively, that probate be granted in solemn form of that will to the executor.
Griffiths AJ held, dismissing the plaintiff's case in its entirety, and granting the alternative relief sought by way of cross-claim:
(i) Formal validity
The Thai will is a valid testamentary instrument under s 6 of the Succession Act 2006 (NSW), thus superseding the Australian will, and is to be taken as evidencing the most recent testamentary intentions of the testatrix: [206]-[207].
(ii) Essential validity
The parties agreed that the testatrix was domiciled in NSW, and consequently, it was NSW laws on testamentary capacity that applied. In light of the applicable principles, the second defendant discharged his onus of proving the testatrix had testamentary capacity when the Thai will was executed: [244]. The instrument is rational and made substantial provision for each of the two beneficiaries: [221]. The lay evidence revealed the testatrix maintained appreciable levels of business acumen, social intuit and awareness of her surroundings, signifying a level of cognition which demonstrated her testamentary intentions were those as captured in the Thai will: [223]-[243]. Expert medical evidence tendered by the plaintiff did not displace these findings, and was accorded limited weight, including because of the fact that the two experts were not treating physicians: [197]-[198].
Banks v Goodfellow (1870) LR 5 QB 549; Tobin v Ezekiel (2012) 83 NSWLR 757; [2012] NSWCA 285; Lim v Lim [2023] NSWCA 84, considered.
Relatedly, there was no evidence of the testatrix not having knowledge and approval of the contents of the latter will and there were no circumstances arousing the Court's suspicion that this document did not have her full consent: [248].
(iii) Family provision claim
The plaintiff's case for a family provision order to be made in her favour was made out of time, namely more than 12 months after the testatrix's death, and no acceptable explanation was provided for the failure to seek the order within time: [251]; [255]. It was also evident that the claim was made as an afterthought, as little evidence or attention was directed to it, and moreover, the plaintiff was not forthcoming as to the true extent of her financial circumstances: [269]-[279]. The plaintiff thus failed to discharge her onus of establishing her claim: [285]-[287].
Thomas v Pickering; Byrne v Pickering [2011] NSWSC 572; Taylor v Farrugia [2009] NSWSC 801, considered.
(iv) Determination of cross-claim
A grant of probate in solemn form of the Thai will was apposite in the circumstances: [288]. Though some formalities were not adhered to in the filing of the cross-claim, this did not bar the granting of the alternative case in the circumstances: [292]-[293].
headnote
JUDGMENT
A. Introduction
B. Some uncontroversial background matters summarised
(a) Amy's estate and her two wills
(b) A broad chronology
Purchase of the Mosman Property and Boon Luck Farm
Execution of the Australian will
Lung cancer diagnosis
Execution of the Thai will
Events following the execution of the Thai will
C. The lay and medical evidence summarised and assessed
(a) The parties' lay evidence
The plaintiff's witnesses
(i) Palisa
(ii) Matt
The second defendant's witnesses
(i) Bob's evidence
(ii) Mr Kasemnate's evidence
(iii) Ms Klaisoi's evidence
(iv) Ms Srisomboon's evidence
(v) Fern's evidence
Fern's "ping pong" evidence
(vi) Pat's evidence
(b) Palisa's medical evidence
(i) Dr Dua
(a) Dexamethasone
(b) Osimertinib
(c) Fentanyl
(d) Levetiracetam (also known as Keppra)
My assessment of Dr Dua's evidence
(ii) Professor Ogden
(a) Levetiracetam / Keppra
(b) Dexamethasone
(c) Vitamin B (prescribed supplement)
(d) Thiamine (prescribed supplement)
(e) Cyproheptadine
(f) Tramadol
(g) Fentanyl
(h) Morphine
(i) Osimertinib
(j) Olanzapine
(k) Lorazepam
Professor Ogden's supplementary expert report
My assessment of Professor Ogden's evidence
(iii) Conclusions on the expert medical evidence
D. Consideration and determination of Palisa's case
(i) Some private international law principles summarised
Formal validity of the 2020 will
Applicable law in determining questions of capacity
(ii) Amy's testamentary capacity
Amy's understanding of the nature and significance of the act of making a will
Amy's understanding of the nature and value of her estate
Ability to call to mind and to weigh competing claims
(a) Inferences drawn from the Thai will itself
(b) Amy's explanation of her testamentary intentions
(c) Amy's cognitive ability displayed in her interactions with colleagues and third persons
(d) Palisa's interactions with Amy
(e) Observations of third party lay witnesses
(f) Conclusion on Amy's testamentary capacity
(iii) Knowledge and approval of Thai will
Conclusion on knowledge and approval
(iv) Family provision claim
Extension of time application
Relevant considerations in making family provision order
Relationship between Palisa and the deceased (s 60(2)(a))
Nature and extent of the estate (s 60(2)(c))
Palisa's financial resources (s 60(2)(d))
Palisa's health (s 60(2)(f))
Palisa's age (s 60(2)(g))
Palisa's contribution (s 60(2)(h))
Amy's testamentary intentions (s 60(2)(j))
Circumstances of the competing beneficiaries (ss 60(2)(b), 60(2)(d))
(vi) Conclusion as to appropriate provision
E. Consideration and determination of Pat's cross-claim
F. Costs
G. Conclusion